Rosas-Guerra OZ, Marín-Méndez JA

Language: Spanish
References: 15
Page: 150-154
PDF size: 190.96 Kb.

ABSTRACT

Background. The minimally invasive parathyroidectomy, guided by intraoperative measurement of parathyroid hormone (PTH) is widely accepted in the treatment of sporadic primary hyperparathyroidism, it has already demonstrated its feasibility, safety and efficacy with lower morbidity and surgical time compared to classical bilateral neck exploration. Objective. Show the experience in Hospital Ángeles Metropolitano. Material and methods. Observational, descriptive and retrospective study of medical records of patients diagnosed with sporadic primary hyperparathyroidism, operated by minimally invasive where intraoperative PTH measurements was used. Results. Thirteen patients, 8 women and 5 men. The mean preoperative PTH was 464.2, pg/mL, 15 min after resection decreased by 83.06%, no patient had complications. With 100% cure. Conclusion. Measurement intraoperative of PTH is useful and safe, is a guided resection adjuvant functional parathyroid tissue to avoid major surgery and high morbidity.

REFERENCES

1. Delgadillo Teyer GH, Fenig Rodríguez J, González Romero F, Velazquez García JA, Serrano Galeana I, Bevia Pérez F. Experiencia de 15 años en el tratamiento quirúrgico del Hiperparatiroidismo. Cirujano General 2005; 27(2): 149-51.

2. Mendoza Zubieta V, Ramírez Renteria C, González Villaseñor GA, Espinoza Barrones AE, Peña García JF, Hernandez García I, et al. Hiperparatiroidismo primario. Experiencia en el Hospital de Especialidades Centro Médico Nacional Siglo XXI. Revista de Endocrinología y Nutrición 2009; 17(1): 13-20.

3. Wong W, Foo FJ, Lau MI, Sarin A, Kiruparan P. Simplified minimally invasive parathyroidectomy: a series of 100 cases and review of the literature. Ann R Coll Surg Engl 2011; 93(4): 290-3.

4. Granados Canseco E, Servín Torres E, Piscil Salazar MA, Velázquez García JA, Serrano Galeana I, Granado Canseco R, et al. Experiencia quirúrgica en el Hiperparatiroidismo primario en el Hospital de Especialidades del Centro Médico “La Raza”. Cirujano General 2012; 34(4): 249-53.

5. Zawawi F, Mlynarek AM, Cantor A, Varshney R, Black MJ, Hier MP, et al. Intraoperative parathyroid hormone level in parathyroidectomy: which patients benefit from it? J Otolaryngol Head Neck Surg 2013; 42(1): 56-61.

6. Gutiérrez Diaz Ceballo ME, Rodríguez Martinez HA, Torres Acosta EM, Cruz Ortiz H. Hiperparatiroidismo primario. Rev Fac Med 2001; 44(1): 32-34.

7. Mohebati A, Shaha AR. Imaging techniques in parathyroid surgery for primary Hyperparathyroidism. Am J Otolaryngol 2012; 33(4): 457-68.

8. Calò PG, Pisano G, Loi G, Medas F, Tatti A, Piras S, et al. Surgery for Primary Hyperparathyroidism in Patients with Preoperatively Negative Sestamibi Scan and Discordant Imaging Studies: The Usefulness of Intraoperative Parathyroid Hormone Monitoring. Clin Med Insights Endocrinol Diabetes 2013; 6: 63-7.

9. Udelsman R, Donovan PI. Open minimally invasive parathyroid surgery. World J Surg 2004; 28(12): 1224-6.

10. Inabnet WB. Intraoperative parathyroid hormone monitoring. World J Surg 2004; 28(12): 1212-5.

11. Irvin GL, Solorzano CC, Carneiro DM. Quick Intraoperative Parathyroid Hormone Assay: Surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 2004; 28(12): 1287-92.

12. Hanif F, Coffey JC, Romics L Jr, O’Sullivan K, Aftab F, Redmond HP. Rapid intraoperative parathyroid hormone assay-more than just a comfort measure. World J Surg 2006; 30(2): 156-61.

13. Westerdahl J, Bergenfelz A. Sestamibi scan-directed parathyroid surgery: potentially high failure rate without measurement of intraoperative parathyroid hormone. World J Surg 2004; 28: 1132-8.

14. Castillo Núñez Y, Reza Albarran A. Manejo del hiperparatiroidismo primario asintomático. Revista de Endocrinología y Nutrición 2009; 17(1): 36-45.

15. Schneider DF, Mazet H, Chen H, Sippel RS. Predictors of recurrence in primary hyperparathyroidism: an analysis of 1,386 cases. Ann Surg 2014; 259(3): 563-8.